cumulus-neuroscience
Founded 2015 · 2 known investors
Cumulus Neuroscience develops the NeuLogiq platform, which combines digital cognitive assessments and neurophysiological (brain function) data for in-clinic and at-home longitudinal monitoring. It serves pharmaceutical companies and researchers running CNS clinical trials, providing objective real-world endpoints to support central nervous system drug development.
BiotechDigital HealthHealthtech
Investors · 2
Frequently asked questions
- What does cumulus-neuroscience do?
- Cumulus Neuroscience develops the NeuLogiq platform, which combines digital cognitive assessments and neurophysiological (brain function) data for in-clinic and at-home longitudinal monitoring. It serves pharmaceutical companies and researchers running CNS clinical trials, providing objective real-world endpoints to support central nervous system drug development.
- Who are cumulus-neuroscience's investors?
- cumulus-neuroscience's investors include Clarendon Fund Managers Ltd., LifeArc Ventures.